Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018

ASSTON PHARMACEUTICALS LIMITED (FORMERLY KNOWN AS ASSTON PHARMACEUTICALS PRIVATE LIMITED) Date: 14th October, 2026 BSE Limited Listing / Compliance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400051 Sub: - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30th September, 2026. Dear Sir/Madam, Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby enclose the certificate for the quarter ended 30th September, 2026, as received from the Registrar and Share Transfer Agent of the Company, M/s. Maashitla Securities Private Limited. This is submitted for your information and records. Kindly acknowledge receipt of the same. Yours Truly, For: Asston Pharmaceuticals Limited Rishi Upadhaya Company Secretary and Compliance Officer A74324 CIN: U24304MH2019PLC324187 Reg. Office- 4th Floor Office No A-431 Balaji Bhavan, Plot No 42a Sector-11 CBD Belapur, Navi Mumbai, Thane, Maharashtra, 400614, India Phone No.: 022-49731419 / 49731411, Email id: aston.tech14@gmail.com/compliance@asstonpharmaceuticals.com Web: www.asstonpharmaceuticals.com